Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Tax Withholding of 14 JAZZ shares, $3.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 14 | $3.4K |
| Aug 7, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 1,605 | n/a |
| Aug 4, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 10,000 | n/a |
| Apr 22, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Exercise/Conversion | 12,500 | $91.4K |
| Mar 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Exercise/Conversion | 3,415 | $471.5K |
| Feb 5, 2026 | Eton Pharmaceuticals, Inc. (ETON) | In-the-Money Exercise | 30,000 | $132.6K |
| Jan 14, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 12,196 | n/a |
| Aug 11, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 3,507 | n/a |
| Jan 6, 2025 | Eton Pharmaceuticals, Inc. (ETON) | Exercise/Conversion | 27,400 | $98.1K |
| Jan 6, 2025 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 25,000 | n/a |